Mahmoud Shorman

696 total citations
42 papers, 504 citations indexed

About

Mahmoud Shorman is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Mahmoud Shorman has authored 42 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Infectious Diseases, 22 papers in Epidemiology and 10 papers in Clinical Biochemistry. Recurrent topics in Mahmoud Shorman's work include Antimicrobial Resistance in Staphylococcus (15 papers), Bacterial Identification and Susceptibility Testing (10 papers) and Infective Endocarditis Diagnosis and Management (10 papers). Mahmoud Shorman is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (15 papers), Bacterial Identification and Susceptibility Testing (10 papers) and Infective Endocarditis Diagnosis and Management (10 papers). Mahmoud Shorman collaborates with scholars based in United States, Saudi Arabia and Egypt. Mahmoud Shorman's co-authors include Michael P. Veve, Jaffar A. Al‐Tawfiq, Ahmad M. Al-Majali, Hoda Hassan, Baha Abdalhamid, Nimish Patel, R. Eric Heidel, Elaine S. Walker, Jehad Abdalla and Felix A. Sarubbi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Clinical Microbiology.

In The Last Decade

Mahmoud Shorman

40 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mahmoud Shorman United States 14 245 209 103 95 76 42 504
Krispin Hajkowicz Australia 14 358 1.5× 434 2.1× 73 0.7× 65 0.7× 72 0.9× 33 669
Kerry O. Cleveland United States 12 292 1.2× 399 1.9× 55 0.5× 85 0.9× 49 0.6× 53 622
Brian C. Pien United States 9 194 0.8× 224 1.1× 133 1.3× 113 1.2× 29 0.4× 11 501
J.A. Karas United Kingdom 13 382 1.6× 258 1.2× 65 0.6× 61 0.6× 42 0.6× 28 560
Sandra Valderrama Colombia 14 248 1.0× 230 1.1× 47 0.5× 93 1.0× 45 0.6× 49 512
Timothy Gray Australia 11 129 0.5× 116 0.6× 67 0.7× 50 0.5× 61 0.8× 23 360
Hasan Bhally New Zealand 11 185 0.8× 236 1.1× 116 1.1× 87 0.9× 40 0.5× 23 450
Sami KINIKLI Türkiye 12 176 0.7× 98 0.5× 39 0.4× 109 1.1× 58 0.8× 70 408
Shi Nae Yu South Korea 13 181 0.7× 139 0.7× 80 0.8× 65 0.7× 113 1.5× 38 443
Roberta Maria Antonello Italy 12 211 0.9× 186 0.9× 20 0.2× 74 0.8× 59 0.8× 31 488

Countries citing papers authored by Mahmoud Shorman

Since Specialization
Citations

This map shows the geographic impact of Mahmoud Shorman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mahmoud Shorman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mahmoud Shorman more than expected).

Fields of papers citing papers by Mahmoud Shorman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mahmoud Shorman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mahmoud Shorman. The network helps show where Mahmoud Shorman may publish in the future.

Co-authorship network of co-authors of Mahmoud Shorman

This figure shows the co-authorship network connecting the top 25 collaborators of Mahmoud Shorman. A scholar is included among the top collaborators of Mahmoud Shorman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mahmoud Shorman. Mahmoud Shorman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shorman, Mahmoud, et al.. (2023). Missed Opportunities for Antifungal Stewardship during the COVID-19 Era. Antibiotics. 12(9). 1352–1352. 1 indexed citations
3.
Veve, Michael P., et al.. (2020). Comparison of dalbavancin to standard-of-care for outpatient treatment of invasive Gram-positive infections. International Journal of Antimicrobial Agents. 56(6). 106210–106210. 37 indexed citations
4.
Chahin, Abdullah, et al.. (2020). COVID-19 pandemic in Yemen: A questionnaire based survey, what do we know?. The Journal of Infection in Developing Countries. 14(12). 1374–1379. 6 indexed citations
5.
Veve, Michael P., et al.. (2020). Epidemiology and outcomes of non-HACEK infective endocarditis in the southeast United States. PLoS ONE. 15(3). e0230199–e0230199. 39 indexed citations
6.
Veve, Michael P., et al.. (2019). Long-term vancomycin use had low risk of ototoxicity. PLoS ONE. 14(11). e0224561–e0224561. 22 indexed citations
7.
Heidel, R. Eric, et al.. (2019). Microbial Epidemiology of Infectious Endocarditis in the Intravenous Drug Abuse Population: A Retrospective Study. Infectious Diseases and Therapy. 8(1). 113–118. 11 indexed citations
8.
AlJindan, Reem, et al.. (2018). First description of plasmid mediated quinolone resistance genes in salmonella isolates from Saudi hospitals. Saudi Medical Journal. 39(7). 685–689. 2 indexed citations
9.
Shorman, Mahmoud, et al.. (2016). Bacteremia with an Unusual Pathogen:Mycobacterium neoaurum. SHILAP Revista de lepidopterología. 2016. 1–3. 6 indexed citations
10.
11.
12.
Alghamdi, Ali S., et al.. (2013). Chaetomium peritonitis in an immunocompetent patient simulating tuberculous peritonitis: A case report and review of the literature. 1(1). 1–5. 4 indexed citations
13.
Shorman, Mahmoud & Jaffar A. Al‐Tawfiq. (2013). Risk Factors Associated with Vancomycin-ResistantEnterococcusin Intensive Care Unit Settings in Saudi Arabia. Interdisciplinary Perspectives on Infectious Diseases. 2013. 1–4. 16 indexed citations
14.
AbuBakar, Sazaly, et al.. (2012). In vitroactivity of tigecycline againstAcinetobacter baumanniiisolates from a teaching hospital in Malaysia. Journal of Chemotherapy. 24(2). 87–92. 4 indexed citations
15.
Attia, Adel, et al.. (2012). Evaluation of pleural fluid human epididymis 4 (HE4) as a marker of malignant pleural effusion. Tumor Biology. 33(5). 1701–1707. 21 indexed citations
16.
17.
Shorman, Mahmoud & Jaffar A. Al‐Tawfiq. (2009). Strongyloides stercoralis hyperinfection presenting as acute respiratory failure and Gram-negative sepsis in a patient with astrocytoma. International Journal of Infectious Diseases. 13(5). e288–e291. 17 indexed citations
18.
Al-Majali, Ahmad M. & Mahmoud Shorman. (2008). Childhood brucellosis in Jordan: prevalence and analysis of risk factors. International Journal of Infectious Diseases. 13(2). 196–200. 27 indexed citations
19.
Shorman, Mahmoud, et al.. (2008). Identification of Methicillin Resistant Staphylococcus aureus (MRSA) and Methicillin Resistant Coagulase-Negative Staphylococcus (CoNS) in Clinical Settings. American Journal of Infectious Diseases. 4(2). 156–161. 5 indexed citations
20.
Walker, Elaine S., et al.. (2004). A Decline in Mupirocin Resistance in Methicillin-ResistantStaphylococcus aureusAccompanied Administrative Control of Prescriptions. Journal of Clinical Microbiology. 42(6). 2792–2795. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Krispin Hajkowicz Breakdown of academic impact, for papers by Kerry O. Cleveland Breakdown of academic impact, for papers by Brian C. Pien Breakdown of academic impact, for papers by J.A. Karas Breakdown of academic impact, for papers by Sandra Valderrama Breakdown of academic impact, for papers by Timothy Gray Breakdown of academic impact, for papers by Hasan Bhally Breakdown of academic impact, for papers by Sami KINIKLI Breakdown of academic impact, for papers by Shi Nae Yu Breakdown of academic impact, for papers by Roberta Maria Antonello
Rankless by CCL
2026